Xponance’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
10,910
-675
| -6% | -$14.6K | ﹤0.01% | 1249 |
|
|
2025
Q1 | $192K | Buy |
11,585
+1,434
| +14% | +$23.8K | ﹤0.01% | 1280 |
|
|
2024
Q4 | $186K | Buy |
+10,151
| New | +$186K | ﹤0.01% | 1304 |
|
|
2024
Q1 | – | Sell |
-9,552
| Closed | -$299K | – | 1312 |
|
|
2023
Q4 | $299K | Buy |
+9,552
| New | +$299K | ﹤0.01% | 1065 |
|
|
2021
Q2 | – | Sell |
-11,827
| Closed | -$305K | – | 1248 |
|
|
2021
Q1 | $305K | Buy |
11,827
+216
| +2% | +$5.57K | 0.01% | 958 |
|
|
2020
Q4 | $621K | Buy |
11,611
+44
| +0.4% | +$2.35K | 0.01% | 647 |
|
|
2020
Q3 | $477K | Buy |
11,567
+338
| +3% | +$13.9K | 0.01% | 662 |
|
|
2020
Q2 | $544K | Buy |
+11,229
| New | +$544K | 0.01% | 562 |
|